These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24919609)

  • 21. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?
    Poon RT; Fan ST; Lo CM; Liu CL; Lam CM; Yuen WK; Yeung C; Wong J
    Ann Surg; 2002 Nov; 236(5):602-11. PubMed ID: 12409666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blinded prospective randomized trial comparing the effect of anatomic versus non-anatomic resection on hepatocellular carcinoma recurrence.
    Feng X; Su Y; Zheng S; Xia F; Ma K; Yan J; Li X; Tang W; Wang S; Bie P; Dong J
    HPB (Oxford); 2017 Aug; 19(8):667-674. PubMed ID: 28499749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
    Takahara T; Wakabayashi G; Beppu T; Aihara A; Hasegawa K; Gotohda N; Hatano E; Tanahashi Y; Mizuguchi T; Kamiyama T; Ikeda T; Tanaka S; Taniai N; Baba H; Tanabe M; Kokudo N; Konishi M; Uemoto S; Sugioka A; Hirata K; Taketomi A; Maehara Y; Kubo S; Uchida E; Miyata H; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):721-7. PubMed ID: 26096910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Outcomes of Mesohepatectomy for Centrally Located Liver Tumors: Two-Decade Single-Center Experience.
    Mehrabi A; Ramouz A; Golriz M; Khajeh E; Hackert T; Müller-Stich B; Strobel O; Hoffmann K; Büchler MW;
    J Am Coll Surg; 2022 Aug; 235(2):257-266. PubMed ID: 35839400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
    Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
    Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma.
    Liu P; Yang JM; Niu WY; Kan T; Xie F; Li DQ; Wang Y; Zhou YM
    World J Gastroenterol; 2010 Mar; 16(9):1123-8. PubMed ID: 20205285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher complication rate in hepatocellular carcinoma patients undergoing prophylactic cholecystectomy with curative hepatic resection.
    Kaibori M; Kubo S; Nagano H; Hayashi M; Nakai T; Ishizaki M; Matsui K; Uenishi T; Takemuraz S; Wada H; Marubashi S; Komeda K; Hirokawa F; Nakata Y; Uchiyama K; Kwon M
    Hepatogastroenterology; 2014 Oct; 61(135):2028-34. PubMed ID: 25713906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.
    Lim C; Compagnon P; Sebagh M; Salloum C; Calderaro J; Luciani A; Pascal G; Laurent A; Levesque E; Maggi U; Feray C; Cherqui D; Castaing D; Azoulay D
    HPB (Oxford); 2015 Jul; 17(7):611-23. PubMed ID: 25980326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R1 hepatectomy with exposure of tumor surface for centrally located hepatocellular carcinoma.
    Yu W; Rong W; Wang L; Wu F; Xu Q; Wu J
    World J Surg; 2014 Jul; 38(7):1777-85. PubMed ID: 24370545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanded Makuuchi's criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection.
    Kobayashi Y; Kiya Y; Sugawara T; Nishioka Y; Hashimoto M; Shindoh J
    HPB (Oxford); 2019 Aug; 21(8):990-997. PubMed ID: 30711244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study.
    Zhang F; Yan J; Feng XB; Xia F; Li XW; Ma KS; Bie P
    World J Gastroenterol; 2015 Sep; 21(35):10159-65. PubMed ID: 26401080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early versus late recurrence of centrally located hepatocellular carcinoma after mesohepatectomy: A cohort study based on the STROBE guidelines.
    Zhao J; Li W; Mao J
    Medicine (Baltimore); 2019 Jun; 98(23):e15540. PubMed ID: 31169667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?
    Khandoga A; Drefs M; Schoenberg M; Schiergens T; Frenes K; Op den Winkel M; Trumm C; Angele MK; Guba M; Werner J; Rentsch M
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1045-1053. PubMed ID: 28562395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma.
    Zuo CH; Qiu XX; Ouyang YZ; Zhang D; Xiao H; Mo SC; Tan CQ; Tang M; Zhu HZ
    Mol Clin Oncol; 2014 Sep; 2(5):833-838. PubMed ID: 25054054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.